Drug recall · July 19, 2017
Potassium PHOSphate added to 250 mL 0.9% Sodium Chloride 15 mMol recall
Why: Lack of sterility assurance
Class II: could cause temporary or reversible health problems; serious harm is remote.
The recall
- Product
Potassium PHOSphate added to 250 mL 0.9% Sodium Chloride 15 mMol (22 mEq K+) Total Approximate Volume 255 mL, Rx only, SCA Pharmaceuticals, Little Rock, AR 72205, NDC 70004-0841-40
- Lots / codes
Lot #: 20170509@6, Exp 6/23/2017; 20170519@35, Exp 7/3/2017; 20170523@22, Exp 7/7/2017; 20170525@9, Exp 7/9/2017; 20170605@49, Exp 7/20/2017; 20170605@9, Exp 7/20/2017
- Quantity
- 660 bags
- Company
- SCA Pharmaceuticals, Little Rock, AR
- Distribution
- LA, PA, NY, WI
- Initiated
- June 21, 2017 · Voluntary: Firm initiated
- Classified
- July 13, 2017
- Reported
- July 19, 2017
- Ended
- April 3, 2019
- How notified
- Letter
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Recalled with it (same recall event)
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.